We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$31.9B
AUM Growth
+$2.42B
Cap. Flow
+$75.7M
Cap. Flow %
0.24%
Top 10 Hldgs %
7.9%
Holding
3,245
New
801
Increased
908
Reduced
911
Closed
472

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$272M
2
PYPL icon
PayPal
PYPL
+$237M
3
TSLA icon
Tesla
TSLA
+$223M
4
AMD icon
Advanced Micro Devices
AMD
+$169M
5
COR icon
Cencora
COR
+$165M

Sector Composition

Rank Sector Weight
1 Technology 16.55%
2 Healthcare 16.06%
3 Financials 11.25%
4 Industrials 10.24%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
2601
GeneDx Holdings
WGS
$2.3B
$36K ﹤0.01%
+4,139
New +$91.2K
LCTX icon
2602
Lineage Cell Therapeutics
LCTX
$278M
$35.9K ﹤0.01%
+30,662
New +$38.6K
MYO icon
2603
Myomo
MYO
$56.2M
$35.6K ﹤0.01%
+69,606
New +$69.3K
ONCS
2604
DELISTED
OncoSec Medical Incorporated
ONCS
$35.5K ﹤0.01%
+21,111
New +$118K
QCLS
2605
Q/C Technologies Inc
QCLS
$22.9M
$34.6K ﹤0.01%
+10
New +$62.8K
APTO
2606
DELISTED
Aptose Biosciences, Inc.
APTO
$34.4K ﹤0.01%
132
-60
-31% -$16.1K
SUPV
2607
Grupo Supervielle
SUPV
$753M
$34.2K ﹤0.01%
+15,836
New +$29.1K
NEUE
2608
DELISTED
NeueHealth
NEUE
$34.1K ﹤0.01%
656
+246
+60% +$17.9K
PVLA
2609
Palvella Therapeutics
PVLA
$2.27B
$34K ﹤0.01%
408
-64
-14% -$5.14K
HTT
2610
High Templar Tech Ltd
HTT
$391M
$33.6K ﹤0.01%
+35,300
New +$30.9K
BRN icon
2611
Barnwell Industries
BRN
$14.1M
$33.5K ﹤0.01%
11,338
-4,001
-26% -$12.1K
GIGM icon
2612
GigaMedia
GIGM
$16.4M
$33.4K ﹤0.01%
27,620
-3,775
-12% -$4.64K
HUT
2613
Hut 8
HUT
$10.9B
$33K ﹤0.01%
+7,768
New +$58.5K
ADAP
2614
DELISTED
Adaptimmune Therapeutics
ADAP
$33K ﹤0.01%
+22,600
New +$36.6K
CRDF icon
2615
Cardiff Oncology
CRDF
$77.2M
$32.6K ﹤0.01%
+23,309
New +$33.4K
NVVE
2616
DELISTED
Nuvve Holding Corp
NVVE
0
AMS icon
2617
American Shared Hospital Services
AMS
$9.87M
$31.4K ﹤0.01%
10,723
ARQQW icon
2618
Arqit Quantum Warrants
ARQQW
$133K
$31.1K ﹤0.01%
+61,000
New +$56.2K
SIOX
2619
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$30.9K ﹤0.01%
70,925
NNVC icon
2620
NanoViricides
NNVC
$36.2M
$30.7K ﹤0.01%
27,693
-6,500
-19% -$10.1K
ENSC icon
2621
Ensysce Biosciences
ENSC
$7.99M
$29.9K ﹤0.01%
+222
New +$105K
FABC
2622
Fabric.AI Inc
FABC
$18.4M
$29.4K ﹤0.01%
599
-92
-13% -$6.45K
GERN icon
2623
Geron
GERN
$949M
$29.3K ﹤0.01%
12,100
-573,627
-98% -$1.29M
ZNB
2624
Zeta Network Group
ZNB
$2.4M
0
MKFG
2625
DELISTED
Markforged Holding Corporation
MKFG
$28.7K ﹤0.01%
+2,471
New +$37.6K

Similar funds

Two Sigma Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Two Sigma Investments held 3,245 positions worth $31.9B, up 8.2% from $29.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Two Sigma Investments's Q4 2022 filing shows 801 new, 908 increased, 911 reduced and 472 closed positions. Its largest new stake was Yum! Brands: 1,187,068 shares worth $152M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $293M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q4 2022 buy was Yum! Brands: 1,187,068 shares worth $152M.
  • Two Sigma Investments added most to Amazon in Q4 2022, an estimated $272M increase.
  • Two Sigma Investments's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $293M.
  • Two Sigma Investments fully exited JPMorgan Chase in Q4 2022, selling an estimated $226M.
  • Two Sigma Investments's ten largest holdings make up 7.9% of its $31.9B portfolio in Q4 2022.
  • Two Sigma Investments opened 801 new positions and closed 472 in Q4 2022.
  • Two Sigma Investments's portfolio value rose 8.2% quarter-over-quarter to $31.9B.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.